Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
IMV Inc
IMVIF
Healthcare
Biotechnology
IMV Inc. is a Canada-based company. The Company has no business operations.
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (GREY:IMVIF)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
(38)
•••
Hideaway
X
View Profile
View Bullboard History
Post by
Hideaway
on Apr 18, 2023 10:27am
Stock Price
Does anyone know what is driving IMV's stock price up?
(1)
•••
gardy
X
View Profile
View Bullboard History
Post by
gardy
on Apr 07, 2023 12:38pm
Nasdaq delisting
Well lets see. Another 10 to 1 rollback will put us at 1.7 million shares. Thats one tight float, LOL. What has happened to this company? Gardy
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 31, 2023 4:15pm
New Press Release - IMV Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
IMV Inc. (“IMV” or the “Company”) (NASDAQ: IMV; TSX: IMV), a clinical-stage company developing a portfolio of immune-educating therapies based on its novel DPX® platform to treat solid and hematologic cancers, today announced that on March 29, 2023, IMV Inc. (the “Company”) received a letter from...
read article.
(10)
•••
prosciutto
X
View Profile
View Bullboard History
Post by
prosciutto
on Mar 28, 2023 6:29pm
Stonegate - Looks like I got it wrong
No MBA from St Marys, but it looks like they appointed a B Comm from St Marys to the board. Nice! Clever choice. Just in time to go bankrupt.
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 27, 2023 4:15pm
New Press Release - IMV Inc. Announces Changes to Its Board of Directors
IMV Inc. (NASDAQ: IMV; TSX: IMV), a clinical-stage company developing a portfolio of immune-educating therapies, based on its novel DPX platform, to treat solid and hematologic cancers, today announced changes to its board of directors as Shermaine Tilley, Ph.D., MBA has resigned from the Board...
read article.
(7)
•••
Sandinista
X
View Profile
View Bullboard History
Comment by
Sandinista
on Mar 17, 2023 7:44pm
RE:RE:24 year old
sorry, for some reason it didn't post the copy of the transript. I'll try again, as follows: We are learning alongside renewed interest in this whole field of cancer vaccines that DPX-enabled
...more
(7)
•••
Sandinista
X
View Profile
View Bullboard History
Comment by
Sandinista
on Mar 17, 2023 7:39pm
RE:24 year old
It is real - these are Andrew Hall's words at the Fourth Quarter and Fiscal 2022 webcast, given on March 16, 2023. It can be found on the company webpage at Fourth Quarter and Fiscal Year
...more
(2)
•••
europe10
X
View Profile
View Bullboard History
Comment by
europe10
on Mar 17, 2023 4:38pm
RE:24 year old
Is this true?.....
(10)
•••
prosciutto
X
View Profile
View Bullboard History
Post by
prosciutto
on Mar 17, 2023 1:57pm
24 year old
I ask: why dont they interview this guy, put the video on youtube, generate some buzz I want to highlight one of those complete responses in VITALIZE that was presented at the recent IO360
...more
(10)
•••
prosciutto
X
View Profile
View Bullboard History
Post by
prosciutto
on Mar 17, 2023 1:35am
Stonegate
Well at least they are reaching out across the border and not getting advice from an MBA from St. Mary's If anyone is interested here is the link : https://stonegateinc.com/healthcare/
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 16, 2023 7:06am
New Press Release - IMV Inc. Announces Strategic Update as well as Fourth Quarter and Full Year 2022 Financial and Operational Results
Advanced lead candidate, MVP-S, in two global Phase 2B clinical trials and enhanced the scientific differentiation of the DPX platformObserved multiple complete clinical responses in relapsed/refractory DLBCL and expect to complete enrollment of stage one in the VITALIZE study in Q2...
read article.
(2)
•••
antigua1987
X
View Profile
View Bullboard History
Post by
antigua1987
on Mar 15, 2023 8:45am
Prediction - mvp-s bladder trial and search ...
for partner has ended. new website (same shade of plum though) and milestone table drops mvps bladder trial descript "Identification of strategic collaborator, finalize protocols"
...more
(1)
•••
gardy
X
View Profile
View Bullboard History
Comment by
gardy
on Mar 09, 2023 4:20pm
RE:RE:Andy has left the building ...
Agree with all mentioned above. Three things that will move a company forward. # 1 - Management. # 2 - Management. # 3 - Management!! Are you listening Andy. Nasdaq will be delisting us soon if you
...more
(7)
•••
Sandinista
X
View Profile
View Bullboard History
Comment by
Sandinista
on Mar 09, 2023 3:51pm
RE:Andy has left the building ...
Andy, some advice. To drive future stock value, you have to: 1. Have the CEO, CFO, CSO buy stock. To date, none of you have, which contrasts sharply with the previous CEO and CFO (Ors and Labb) who
...more
(0)
•••
PressRelease
X
View Profile
View Bullboard History
Post by
PressRelease
on Mar 09, 2023 7:05am
New Press Release - IMV Inc. to Announce Fourth Quarter and Fiscal Year 2022 Results and Host a Conference Call and Webcast on March 16, 2023
IMV Inc. (NASDAQ: IMV; TSX: IMV), a clinical-stage company developing a portfolio of immune-educating therapies, based on its novel DPX platform, to treat solid and hematologic cancers, today announced that it will hold a conference call and webcast on Thursday, March 16, 2023, at 8:00 a.m. ET to...
read article.
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
...
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
One Property, One Focus on Advancing this Gold Project in Ontario
Options Trading for Retiring: Key Strategies in Balancing Retirement Income